Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000474945 | SCV000544760 | pathogenic | Jeune thoracic dystrophy | 2025-01-06 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 241 of the IFT80 protein (p.Gly241Arg). This variant is present in population databases (rs138004478, gnomAD 0.1%). This missense change has been observed in individuals with short-rib thoracic dysplasia (PMID: 19648123, 29068549, 30266093). ClinVar contains an entry for this variant (Variation ID: 406218). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt IFT80 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. |
ARUP Laboratories, |
RCV003103777 | SCV000604009 | likely pathogenic | Asphyxiating thoracic dystrophy 2 | 2023-06-01 | criteria provided, single submitter | clinical testing | The IFT80 c.721G>C; p.Gly241Arg variant (rs138004478) is reported in the literature in the homozygous or compound heterozygous state in individuals affected with short-rib thoracic dysplasia II, asphyxiating thoracic dystrophy, or Jeune-Verma-Naumoff dysplasia (Cavalcanti 2011, Normand 2018, Zhang 2018). This variant is also reported in ClinVar (Variation ID: 406218), and is found in the African/African-American population with an allele frequency of 0.12% (30/24974 alleles) in the Genome Aggregation Database. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.628). Based on available information, this variant is considered to be likely pathogenic. References: Cavalcanti D et al. Mutation in IFT80 in a fetus with the phenotype of Verma-Naumoff provides molecular evidence for Jeune-Verma-Naumoff dysplasia spectrum. J Med Genet. 2011; 48(2):88-92. PMID: 19648123. Normand EA et al. Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder. Genome Med. 2018 Sep 28;10(1):74. PMID: 30266093. Zhang W et al. Expanding the genetic architecture and phenotypic spectrum in the skeletal ciliopathies. Hum Mutat. 2018 Jan;39(1):152-166. PMID: 29068549. |
Dan Cohn Lab, |
RCV000474945 | SCV000612067 | pathogenic | Jeune thoracic dystrophy | 2017-06-01 | no assertion criteria provided | research | |
Dan Cohn Lab, |
RCV000516104 | SCV000612070 | pathogenic | Short-rib thoracic dysplasia 6 with or without polydactyly | 2017-06-01 | no assertion criteria provided | research | |
Eurofins Ntd Llc |
RCV000727148 | SCV000706155 | uncertain significance | not provided | 2017-03-02 | flagged submission | clinical testing | |
University of Washington Center for Mendelian Genomics, |
RCV000474945 | SCV001479583 | likely pathogenic | Jeune thoracic dystrophy | no assertion criteria provided | research | ||
University of Washington Center for Mendelian Genomics, |
RCV000516104 | SCV001479586 | likely pathogenic | Short-rib thoracic dysplasia 6 with or without polydactyly | no assertion criteria provided | research | ||
Prevention |
RCV004758018 | SCV005356203 | pathogenic | IFT80-related disorder | 2024-07-08 | no assertion criteria provided | clinical testing | The IFT80 c.721G>C variant is predicted to result in the amino acid substitution p.Gly241Arg. This variant was reported in the homozygous state in multiple individuals with short-rib thoracic dysplasia (Cavalcanti et al. 2011. PubMed ID: 19648123; Zhang et al. 2017. PubMed ID: 29068549; Normand et al. 2018. PubMed ID: 30266093). This variant is reported in 0.12% of alleles in individuals of African descent in gnomAD. This variant is interpreted as pathogenic. |